FDA’s First Interchangeable Biosimilar: Floodgate for Others?
Yesterday’s approval of the first interchangeable biosimilar by the FDA provides a proof of concept for biosimilars that will be treated like generic drugs in that they can be substituted for the reference product at the pharmacy without needing a specific prescription. This is a major milestone that has been almost 10 years in the … Read more